| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.20B | $6.11B | $5.87B |
| YoY Revenue Growth % | +1.6% | +4.1% | — |
| Gross Profit | $2.77B | $2.79B | — |
| Gross Margin % | 44.7% | 45.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.08B | $807.1M | $1.06B |
| Operating Margin % | 17.4% | 13.2% | 18.0% |
| Net Income (GAAP) | $736.8M | $585.3M | $755.6M |
| EBITDA (Normalized) | $1.18B | $950.9M | $1.27B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.22B | $1.16B | $1.03B |
| Capital Expenditures (CapEx) | $122.4M | $179.8M | $264.1M |
| Free Cash Flow (FCF) | $1.09B | $976.4M | $766.5M |
| FCF Margin % | 17.6% | 16.0% | 13.1% |
| Return on Invested Capital (ROIC %) | 14.7% | 11.4% | 10.0% |
| Cash & Short-Term Equivalents | $409.0M | $964.1M | — |
| Total Debt (Short + Long Term) | $2.21B | $2.20B | $3.24B |
| Total Stockholders' Equity | $4.00B | $4.36B | $6.64B |